Seema Singhal, MD
Multiple Myeloma Program
Northwestern University Medical School and
Robert H. Lurie Comprehensive Cancer Center
Dr. Seema Singhal received her degree in medicine from Bombay University-Seth GS Medical College in India. She completed her internship at KEM Hospital in Bombay and returned to Bombay University-Seth GS Medical College to complete her residency. She then completed a bone marrow transplant fellowship at Hadassah Hospital in Jerusalem. Dr. Singhal is currently professor of medicine and director, Multiple Myeloma Program, Division of Hematology/Oncology, at Northwestern University Medical School and the Robert H. Lurie Comprehensive Cancer Center at Northwestern University.
Dr. Singhal is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the NCCN Multiple Myeloma Panel. She has edited a book on myeloma and has authored or co-authored over 590 articles, abstracts, and book chapters that have appeared in publications such as the Journal of Clinical Oncology, Blood, Bone Marrow Transplantation, and the New England Journal of Medicine. She also regularly reviews manuscripts for various journals. Dr. Singhal’s current research interests include multiple myeloma with special reference to new treatment approaches including inhibition of angiogenesis, cytogenetic abnormalities, and magnetic resonance imaging; and clinical and experimental autologous and allogeneic hematopoietic stem cell transplantation.
Dr. Singhal has disclosed that she has no significant relationships with the grantor Millennium Pharmaceuticals, Inc. or any other commercial company.